<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04809883</url>
  </required_header>
  <id_info>
    <org_study_id>20-012285</org_study_id>
    <nct_id>NCT04809883</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate Endoflip Normal Ranges Data in Healthy Volunteers</brief_title>
  <official_title>Normative EndoFlip Data on the Diameter and Distensibility of the Pylorus During Fasting and Postprandially in Healthy Females and Male Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to establish the normal range of diameter and distensibility&#xD;
      of pylorus and the fasting and postprandial antro-pyloric motility in healthy adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An Endoflip catheter will be placed through the mouth into the stomach in order to measure&#xD;
      distal antral contractile activity and pyloric diameter and distensibility during fasting and&#xD;
      after the ingestion of a standard meal&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 6, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>fasting and postprandial pyloric diameter</measure>
    <time_frame>1 hour prior to meal and 1 hour following standardized meal</time_frame>
    <description>Change in Pyloric diameter will be measured during fasting and postprandial using Endoflip</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fasting and postprandial pyloric distensibility index</measure>
    <time_frame>1 hour prior to meal and 1 hour following standardized meal</time_frame>
    <description>Change in Pyloric distensibility index will be measured during fasting and postprandial using Endoflip</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fasting and postprandial distal antral motility index</measure>
    <time_frame>1 hour prior to meal and 1 hour following standardized meal</time_frame>
    <description>Change in distal antral motility index will be measured during fasting and postprandial using Endoflip</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>observational study of gastric and pyloric motor function measured with Endoflip</arm_group_label>
    <description>observational study of gastric and pyloric motor function measured with Endoflip during fasting and postprandial periods There is NO intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Endoflip measurement of gastric and pyloric function</intervention_name>
    <description>Endoflip device to measure gastric and pyloric functions</description>
    <arm_group_label>observational study of gastric and pyloric motor function measured with Endoflip</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        healthy adults between the ages of 18 and 65 with body mass indices between 18 and 35&#xD;
        kilograms/meter squared will be recruited for this study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Females and males.&#xD;
&#xD;
          -  Between the ages of 18 and 65 years.&#xD;
&#xD;
          -  Body mass index between 18 and 35 kg/m^2.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Heartburn, regurgitation, or symptoms suggestive of gastroparesis such as nausea,&#xD;
             early satiety, postprandial bloating, and upper abdominal pain.&#xD;
&#xD;
          -  Pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>equal number of males and females will be recruited for this study in up to 45 adults</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Camilleri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Michael Camilleri</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Camilleri, MD</last_name>
      <phone>507-266-2305</phone>
      <email>camilleri.michael@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Irene Busciglio, BS</last_name>
      <phone>5072662305</phone>
      <email>busciglio.irene@mayo.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 2, 2021</study_first_submitted>
  <study_first_submitted_qc>March 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2021</study_first_posted>
  <last_update_submitted>March 19, 2021</last_update_submitted>
  <last_update_submitted_qc>March 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Michael Camilleri, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

